Pharmafile Logo

The Future of Decisioning

August 20, 2026 | Havas Lynx, Point.1 

The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising, while the compressed timelines of global launch cycles demand faster results than ever. We are caught in a paradox: the pressure to accelerate our decision-making is clashing with the absolute necessity for deep, actionable customer understanding.

- PMLiVE

This is why synthetic testing is not just a trend, it’s a strategic imperative.

The Power of SensAI

Point.1’s SensAI is built for Pharma, by Pharma. Our synthetic personas are not generic; they’re constructed from the industry’s most robust comms-based HCP dataset: 11,000+ professionals across 8+ geographies and 10+ therapy areas, with 2,500+ variables per respondent.

And we go further. SensAI integrates Lexicon analysis to identify critical knowledge gaps, hundreds of award-winning case studies to establish “best-in-class” benchmarks, and competitor norms to ensure true brand differentiation. By aligning this data with behavioural science, we create a 360-degree view that transforms raw data into strategic creative scoring.

Putting It to the Test

The common scepticism surrounding synthetic testing is: Can it really replace human insight? We put that question to the test by running a head-to-head comparison with traditional human quantitative research.

The results were statistically compelling. Our synthetic testing achieved an 86% predictive match with human benchmarks, with correlation of R=0.93 for PCPs and R=0.84 for Neurologists.

- PMLiVE

The figures prove that our AI doesn’t just mimic human responses; it mirrors them with high statistical confidence, allowing teams to down-select concepts with rigorous evidence.

A New Framework for the Future

To be clear: synthetic testing is a guide, not a replacement for human judgment. AI is an algorithm, and its value is defined by its foundational architecture. However, when deployed within a testing framework, it allows teams to iterate at speed, killing “dead-on-arrival” concepts before they consume precious human research budgets. It’s about making smarter decisions: 40% faster and significantly cheaper.

Why choose SensAI? Because our dataset is built with Pharma marcomms objectives at its heart. We don’t just understand the HCP’s professional background; we understand their personal drivers, their content preferences, and the specific touchpoints where they engage.

As we move toward a future of faster launches and tighter budgets, the brands that win will be those that use synthetic personas to de-risk their strategy early. The future of decisioning is here, and it is built on robust, data-driven confidence.

This content was provided by Havas Lynx

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx shines a spotlight on carers

Manchester based healthcare communications agency, Havas lynx, has launched its annual white paper campaign, which this year promotes the vital need to support the growing number of carers in our…

SWITCHED ONcology. Healthcare Professionals Focus Group Highlights. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice…

SWITCHED ONcology. Healthcare Professional Experience Focus Group. www.switchedoncology.com

On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice…

SWITCHED ONcology. Caregivers Focus Group Full Discussion. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today’s care continuum, the challenges they face and potential solutions…

SWITCHED ONcology. Caregivers Focus Group Highlights. www.switchedoncology.com

On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today’s care continuum, the challenges they face and potential solutions…

SWITCHED ONcology Patient Experience Focus Group Full Discussion

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In…

SWITCHED ONcology Patient Experience Focus Group Highlights

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. “We…

SWITCHED ONcology

We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched…

18 SWITCHED ONcology: The Big Communication

Matching unprecedented clinical advances in immuno-oncology with transformative communication

17 In Search of the Invisible Army

The caregivers’ story